Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for October 2008.

Pharmaceutical Technology
Volume 32, Issue 10, pp. 108

Acquisition

Allele Biotech and Orbigen Merge

Allele Biotechnology and Pharmaceuticals (San Diego, CA), a biomedical research and service company, acquired Orbigen (San Diego), a company that offers products and services in the fields of antibodies and molecular biology such as the baculovirus expression system.

The companies expect the merger to provide synergy and allow them to meet clients' research needs more efficiently and effectively than before. The combined scientific expertise of both companies has allowed them to expand new research-product lines significantly in areas such as user-friendly fluorescent proteins, novel antibodies, sensitive Luciferase substrates, genotyping products, and various protein-expression systems and assays.

Expansions

Cirrus Offers Walk-In Stability Chambers

Cirrus Pharmaceuticals (Durham, NC) expanded its current capacity for stability storage by adding three walk-in stability chambers from Luwa (Raleigh, NC). Each chamber has 1100 ft3 of storage space, complies with current good manufacturing practices, and meets US Food and Drug Administration guideline requirements for stability. The additions provide long-term, intermediate, and accelerated storage conditions.

The new stability chambers will enable Cirrus to increase its formulation and strategic product-development services for various delivery routes, including inhalation, nasal, parenteral, oral, topical, and transdermal. In addition, Cirrus will enhance its release testing and stability testing in support of clinical trials and regulatory submissions. The chambers, including temperature and humidity mapping and monitoring systems, are scheduled to be completely validated by November 2009.

Nelson Laboratories Breaks Ground On New Building

Nelson Laboratories (Salt Lake City, UT) broke ground on a three-story, 48,000-ft2 addition. The new building will house space for administrative staff, along with the company's biocompatibility, microbiology, and pharmaceutical laboratory departments. The existing space in Nelson's current building will be used to expand all 12 laboratory departments.

Nelson plans to expand the space dedicated to testing in its existing building to better use the facility's infrastructure and engineering. The new building will provide two floors of office space for administrative functions, thereby allowing the company to expand many laboratory areas in the existing building and manage costs. The new building is expected to be complete by August 2009 and will provide needed space for Nelson's growing business.

People

Madeira Names New Advisor

Madeira Therapeutics (Leawood, KS), a new drug-development company specializing in pediatric pharmaceuticals, named David L. Tousley to its board of advisors. Tousley is currently the principal of Stratium Consulting Services, which assists companies with strategic and financial planning and management.

Tousley has more than 25 years of pharmaceutical-development, financial, and process-management experience. Before joining Madeira's board, Tousley held executive positions at airPharma (Overland Park, KS), PediaMed Pharmaceuticals (Florence, KY), AVAX Technologies (Philadelphia, PA), and Pasteur, Merieux, Connaught (Lyon, France).

Regulation

FDA Audits Azopharma Facility

Azopharma Product Development Group's (Hollywood, FL) Cyanta Analytical Laboratories facility in Maryland Heights, Missouri, was successfully audited by the US Food and Drug Administration. The audit produced no Form 483s or other major observations.

Cyanta Analytical Laboratories is a member of the Azopharma Product Development Group and provides analytical testing to the pharmaceutical, biotechnology, and medical-device industries. Cyanta is an emerging leading service provider in the development of inhalation devices. The Cyanta facility was previously audited in 2006. The previous audit produced no Form 483s or major observations.

Website

Farr APC Launches New Dust-Collection Website


Farr APC dust-collection website.
Farr Air Pollution Control (APC, Jonesboro, AR), a leading producer of industrial dust and fume collectors for manufacturing processes, launched a fully redesigned website at http://www.farrapc.com/. The new site provides viewers with information and easy-to-navigate paths to help guide and simplify dust-collection decisions.

The site describes Farr's "Gold Series" flagship line of cartridge dust collectors, as well as "HemiPleat" filters and accessories for new and retrofit use on all types of collectors. The site offers features and technical data, downloadable literature, customer-installation photos, and videos. Visitors to the site can also browse Farr's extensive library of educational materials.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here